Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-013546

Director acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2025-03-17 Grant or award +1,000 $5.17 $5,170 278,843 D
Krogulski Kenneth Director 2025-03-17 Grant or award +4,000 $5.17 $20,680 282,843 D
Loading xslF345X05/wk-form4_1742332498.xml…